Author

M. X. G. Ilagan

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:C. elegans· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

A. S. Kim· 1 shared B. T. Maybruck· 1 shared C. Specht· 1 shared D. Corti· 1 shared D. H. Fremont· 1 shared D. Wang· 1 shared E. S. Theel· 1 shared G. K. Amarasinghe· 1 shared

Activity by Year

2019-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

A. S. Kim

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

MicrobiologybioRxivMay 18, 2020

Neutralizing antibody and soluble ACE2 inhibition of a replication-competent VSV-SARS-CoV-2 and a clinical isolate of SARS-CoV-2.

J. B. Case, P. W. Rothlauf, R. E. Chen…·S. P. J. Whelan

This study develops two neutralization assays for SARS-CoV-2 using VSV and a clinical isolate, showing high concordance between monoclonal, polyclonal antibodies, and ACE2-Fc in neutralizing activity.

DOI 10.1016/j.chom.2020.06.021

experimental assayhost-pathogen & immune response

𝕏 PostBluesky

MicrobiologybioRxivAug 29, 2019

The aminoalkylindole, BML-190, negatively regulates chitosan synthesis via the cAMP/PKA1 pathway in Cryptococcus neoformans

B. T. Maybruck, W. C. Lam, C. Specht…·J. K. Lodge

This paper identifies BML-190 as a compound that reduces chitosan synthesis in Cryptococcus neoformans via the cAMP/PKA1 pathway, suggesting a potential new therapeutic target.

DOI 10.1128/mbio.02264-19

C. elegansexperimental assay

𝕏 PostBluesky